Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades Univar Solns to Hold

Vertical Research Downgrades Univar Solns to Hold

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

byBenzinga Newsdesk

March 14, 2023

1 minute read

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

Analyst Ratings

5 Analysts Have This to Say About Cleveland-Cliffs

By Benzinga Insights

December 5, 2:00 PM

Over the past 3 months, 5 analysts have published their opinion on Cleveland-Cliffs (NYSE:CLF) stock. These analysts are…

CLF

SciSparc Announces Additional Results From The Third Part Of Clearmind Medicine Inc. Pre-Clinical Study For Cocaine Addiction Treatment

By Benzinga Newsdesk

January 17, 9:34 AM

The results of pre-clinical in-vivo research studies suggested that Clearmind's drug candidate MEAI may be effective in the treatment of addiction without interrupting the natural reward process. TEL AVIV, Israel,

SPRC

Analyst Ratings

The Analyst Verdict: Capital One Finl In The Eyes Of 6 Experts

By Benzinga Insights

June 6, 11:01 AM

Across the recent three months, 6 analysts have shared their insights on Capital One Finl (NYSE:COF), expressing a…

COF

AMC Networks Stock Slips: What’s Behind the Sharp Revenue and EPS Decline?

By Anusuya Lahiri

May 10, 9:05 AM

AMC Networks Inc (AMCX) reported Q1 2024 revenue decline of 16.9%, missing analyst estimates. Streaming subscribers increased but stock price fell.

AMCX

Vertical Research Downgrades Univar Solns to Hold

Related Posts

5 Analysts Have This to Say About Cleveland-Cliffs

SciSparc Announces Additional Results From The Third Part Of Clearmind Medicine Inc. Pre-Clinical Study For Cocaine Addiction Treatment

The Analyst Verdict: Capital One Finl In The Eyes Of 6 Experts

AMC Networks Stock Slips: What’s Behind the Sharp Revenue and EPS Decline?